company management team

Bob Boyle co-founded Sentinel Oncology in 2005 with the aim of discovering new technologies and therapies to treat cancer. Bob has 15 years experience of R&D management with positions held at Pfizer, (Sandwich, UK: 1993-1997), Cambridge Discovery Chemistry, (1997-2000), Millennium Pharmaceuticals (2000-2003) and Astex Therapeutics (2003-2005).

Bob has extensive experience in leading research programs with an excellent track record of delivering success and is a named inventor and co-author on many patents and publications.

Stuart Travers co-founded Sentinel Oncology in 2005. Stuart is a Medicinal Chemist by training with a track record of success in multiple therapeutic areas and specifically in Oncology research. With 19 years industrial experience, he has worked in both large pharma (GSK, UK: 1989-1997) and in biotechnology sectors (Cambridge Discovery Chemistry, Millennium Pharmaceuticals, Paradigm Therapeutics: 1997-2005). He was directly responsible as a project manager across multiple disciplines for the successful identification of drug candidates in key areas of Oncology.